Pseudomonas aeruginosa infection
Conditions
Interventions
Observation group treated with different antibacterial drugs:None
Sponsors
The First Affiliated Hospital of Nanchang University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Ceftazidime-tazobactam, polymyxin, ceftazidime-avibactam, imipenem-cilastatin-relibactam, meropenem-ferbortan or amikacin-avibactam for cases treated for more than 3 days
Exclusion criteria
Exclusion criteria: 1.The medication has not been taken for more than three days. 2.Incomplete case information;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Infection indicators (white blood cells, neutrophil percentage, C- reactive protein, procalcitonin, erythrocyte sedimentation rate, etc.); | — |
Secondary
| Measure | Time frame |
|---|---|
| Biochemical indicators (transaminase, bilirubin, albumin, creatinine, urea, creatinine clearance rate, etc.); | — |
Countries
China
Contacts
Public ContactJian Liu
The First Affiliated Hospital of Nanchang University
Outcome results
None listed